High-Performance Size-Based Microdevice for the Detection Of Circulating Tumor Cells from Peripheral Blood in Rectal Cancer Patients

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Sun, Wenjie ^a,b   Jia, Chunping ^c   Huang, Ting ^d   Sheng, Weiqi ^a,b   Li, Guichao ^a,b   Zhang, Honglian ^c   Jing, Fengxiang ^c   Jin, Qinghui ^c   Zhao, Jianlong ^c   Li, Gang ^c   Zhang, Zhen ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI INSTITUTE OF MICROSYSTEM AND INFORMATION TECHNOLOGY   (China)

^d NANTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPITHELIAL CELL ADHESION MOLECULE;

ACCURACY; ANALYTICAL EQUIPMENT; ARTICLE; CANCER CELL CULTURE; CELL COUNT; CELL ISOLATION; CELL STRAIN HT29; CIRCULATING TUMOR CELL; CONTROLLED STUDY; FLOW RATE; FLUORESCENCE MICROSCOPY; FOLLOW UP; HIGH PERFORMANCE MICROFLUIDIC DEVICE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MICROFLUIDICS; PERIPHERAL BLOOD MONONUCLEAR CELL; RECTUM CARCINOMA;

HT29 CELLS; HUMANS; MICROFLUIDIC ANALYTICAL TECHNIQUES; NEOPLASTIC CELLS, CIRCULATING; RECTAL NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 84884176220     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075865     Document Type: Article

References (36)

1. Siegel R, Naishadham D, Jemal A, (2012) Cancer statistics. CA Cancer J Clin 62: 10-29.
2. Byers T, Levin B, Rothenberger D, Dodd GD, Smith RA, (1997) American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer. CA Cancer J Clin 47: 154-160.
3. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, et al. (2000) The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343: 1603-1607.
4. Smith RA, Cokkinides V, Eyre HJ, (2007) Cancer screening in the United States, 2007: a review of current guidelines, practices, and prospects. CA Cancer J Clin 57: 90-104.
5. Crnic I, Christofori G, (2004) Novel technologies and recent advances in metastasis research. Int J Dev Biol 48: 573-581.
6. Pantel K, Brakenhoff RH, Brandt B, (2008) Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 8: 329-340.
7. Mocellin S, Keilholz U, Rossi CR, Nitti D, (2006) Circulating tumor cells: the 'leukemic phase' of solid cancers. Trends Mol Med 12: 130-139.
8. Ross AA, Cooper BW, Lazarus HM, Mackay W, Moss TJ, et al. (1993) Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 82: 2605-2610.
9. Alix-Panabières C, Pantel K, (2013) Circulating tumor cells: liquid biopsy of cancer. Clin Chem 59: 110-118.
10. Joosse SA, Pantel K, (2013) Biologic challenges in the detection of circulating tumor cells. Cancer Res 73: 8-11.
11. Miller MC, Doyle GV, Terstappen LW, (2010) Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer. J Oncol 2010: 617421.
12. Sieuwerts AM, Kraan J, Bolt J, van der Spoel P, Elstrodt F, et al. (2009) Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J Natl Cancer Inst 101: 61-66.
13. Thiery JP, (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454.
14. Tan SJ, Yobas L, Lee GY, Ong CN, Lim CT, (2009) Microdevice for the isolation and enumeration of cancer cells from blood. Biomed Microdevices 11: 883-892.
15. Vona G, Sabile A, Louha M, Sitruk V, Romana S, et al. (2000) Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am J Pathol 156: 57-63.
16. Zhe X, Cher ML, Bonfil RD, (2011) Circulating tumor cells: finding the needle in the haystack. Am J Cancer Res 1: 740-751.
17. Fleischer RL, Alter HW, Furman SC, Price PB, Walker RM, (1972) Particle track etching. Science 178: 255-263.
18. Rostagno P, Moll JL, Bisconte JC, Caldani C, (1997) Detection of rare circulating breast cancer cells by filtration cytometry and identification by DNA content: sensitivity in an experimental model. Anticancer Res 17: 2481-2485.
19. Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, et al. (2007) Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450: 1235-1239.
20. Stott SL, Hsu CH, Tsukrov DI, Yu M, Miyamoto DT, et al. (2010) Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc Natl Acad Sci U S A 107: 18392-18397.
21. Zheng S, Lin H, Liu JQ, Balic M, Datar R, et al. (2007) Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. J Chromatogr A 1162: 154-161.
22. Bhagat AA, Hou HW, Li LD, Lim CT, Han J, (2011) Pinched flow coupled shear-modulated inertial microfluidics for high-throughput rare blood cell separation. Lab Chip 11: 1870-1878.
23. McDonald JC, Duffy DC, Anderson JR, Chiu DT, Wu H, et al. (2000) Fabrication of microfluidic systems in poly(dimethylsiloxane). Electrophoresis 21: 27-40.
24. Hosokawa M, Hayata T, Fukuda Y, Arakaki A, Yoshino T, et al. (2010) Size-selective microcavity array for rapid and efficient detection of circulating tumor cells. Anal Chem 82: 6629-6635.
25. Sheng W, Chen T, Kamath R, Xiong X, Tan W, et al. (2012) Aptamer-enabled efficient isolation of cancer cells from whole blood using a microfluidic device. Anal Chem 84: 4199-4206.
26. Kuo JS, Zhao Y, Schiro PG, Ng L, Lim DS, et al. (2010) Deformability considerations in filtration of biological cells. Lab Chip 10: 837-842.
27. Zhao M, Schiro PG, Kuo JS, Koehler KM, Sabath DE, et al. (2013) An automated high-throughput counting method for screening circulating tumor cells in peripheral blood. Anal Chem 85: 2465-2471.
28. Tanaka F, Yoneda K, Kondo N, Hashimoto M, Takuwa T, et al. (2009) Circulating tumor cell as a diagnostic marker in primary lung cancer. Clin Cancer Res 15: 6980-6986.
29. Sastre J, Maestro ML, Puente J, Veganzones S, Alfonso R, et al. (2008) Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables. Ann Oncol 19: 935-938.
30. Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, et al. (2008) Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 26: 3213-3221.
31. Allen-Mersh TG, McCullough TK, Patel H, Wharton RQ, Glover C, et al. (2007) Role of circulating tumour cells in predicting recurrence after excision of primary colorectal carcinoma. Br J Surg 94: 96-105.
32. Yen LC, Yeh YS, Chen CW, Wang HM, Tsai H, et al. (2009) Detection of KRAS oncogene in peripheral blood as a predictor of the response to cetuximab plus chemotherapy in patients with metastatic colorectal cancer. Clin Cancer Res 15: 4508-4513.
33. Went PT, Lugli A, Meier S, Bundi M, Mirlacher M, et al. (2004) Frequent EpCam protein expression in human carcinomas. Hum Pathol 35: 122-128.
34. Rao CG, Chianese D, Doyle GV, Miller MC, Russell T, et al. (2005) Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors. Int J Oncol 27: 49-57.
35. Hofman V, Ilie MI, Long E, Selva E, Bonnetaud C, et al. (2011) Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method. Int J Cancer 129: 1651-1660.
36. Krebs MG, Hou JM, Sloane R, Lancashire L, Priest L, et al. (2012) Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and-independent approaches. J Thorac Oncol 7: 306-315.